Association between T102C and A–1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs : Clinical Chemical Laboratory Medicine Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Association between T102C and A–1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs

Eva M. Peñas-Lledó 1 / Pedro Dorado2 / Macarena C. Cáceres3 / Alfredo de la Rubia4 / Adrián LLerena5

1CICAB Clinical Research Centre, Servicio Extremeño de Salud, Extremadura University Hospital, Badajoz, Spain and Faculty of Medicine, University of Extremadura, Badajoz, Spain

2CICAB Clinical Research Centre, Servicio Extremeño de Salud, Extremadura University Hospital, Badajoz, Spain and Faculty of Medicine, University of Extremadura, Badajoz, Spain
First two authors contributed equally to this study

3CICAB Clinical Research Centre, Servicio Extremeño de Salud, Extremadura University Hospital, Badajoz, Spain

4Mérida Psychiatric Hospital, Mérida, Spain

5CICAB Clinical Research Centre, Servicio Extremeño de Salud, Extremadura University Hospital, Badajoz, Spain and Faculty of Medicine, University of Extremadura, Badajoz, Spain

Corresponding author: Adrián LLerena, MD, PhD, CICAB Clinical Research Centre, Hospital Universitario Infanta Cristina, Faculty of Medicine, University of Extremadura, Avda. de Elvas, s/n. 06071, Badajoz, Spain Phone: +34-924-289675, Fax: +34-924-218040

Citation Information: Clinical Chemical Laboratory Medicine. Volume 45, Issue 7, Pages 835–838, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: 10.1515/CCLM.2007.181, July 2007

Publication History

Received:
2007-02-09
Accepted:
2007-04-05

Abstract

Background: An involvement of serotonin receptor 2A (5-HT2A) in the aetiology of schizophrenia has been hypothesised. The 5-HT2A receptor also appears to be an important site of action of atypical antipsychotic drugs. Indeed, association between schizophrenia and the T102C silent polymorphism of the 5-HTR2A gene has been reported. Another polymorphism in the promoter region of 5-HTR2A (A–1438G) in linkage disequilibrium with the T102C polymorphism has also been reported. It has been suggested that the A–1438G polymorphism alters promoter activity and expression of 5-HT2A receptors and might be responsible for the associations with schizophrenia and the efficacy of atypical antipsychotics such as risperidone.

Methods: We analysed the 5-HTR2A T102C and A–1438G polymorphisms in clinically stable schizophrenia patients (SPs) and healthy volunteers (HVs). We developed an allele-specific PCR-based restriction fragment length polymorphism (PCR-RFLP) method. In SPs, we also described differences across both diagnosis subtypes (paranoid vs. non-paranoid) and antipsychotic drug treatment (risperidone vs. other classical antipsychotic drugs).

Results: Two groups of 114 SPs and 142 HVs were studied. The frequency of the 5-HTR2A –1438A allele was higher in SPs than in HVs (0.54 vs. 0.44; p<0.05). The frequency of the 102T allele was also higher among SPs than HVs (0.56 vs. 0.46; p<0.05). These two polymorphisms were in linkage disequilibrium. The percentage of carriers of the 1438A/A and 102T/T alleles was 26% and 15% for SPs and HVs, respectively (p<0.05; odds ratio 1.9). No differences in genotype or allele frequencies were found between paranoid and non-paranoid SPs or between SPs on risperidone and those on classical antipsychotic treatment.

Conclusions: The present study demonstrates a higher frequency of 5-HTR2A –1438A and 102T alleles in SPs compared to HVs.

Clin Chem Lab Med 2007;45:835–8.

Keywords: A–1438G polymorphism; T102C polymorphism; risperidone; schizophrenia; seretonin 2A receptor

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Stefanie Malan-Müller, Sanja Kilian, Leigh L. van den Heuvel, Soraya Bardien, Laila Asmal, Louise Warnich, Robin A. Emsley, Sîan M.J. Hemmings, and Soraya Seedat
Schizophrenia Research, 2015
[2]
J M Cooper, D A Newby, I M Whyte, G Carter, A L Jones, and G K Isbister
The Pharmacogenomics Journal, 2014, Volume 14, Number 4, Page 390
[3]
C. Anthony Altar, John Hornberger, Ashwini Shewade, Victor Cruz, Jill Garrison, and David Mrazek
International Review of Psychiatry, 2013, Volume 25, Number 5, Page 509
[4]
Lian Gu, Jianxiong Long, Yan Yan, Qiang Chen, Runde Pan, Xinfeng Xie, Xixiang Mao, Xueying Hu, Bo Wei, and Li Su
Journal of Neuroscience Research, 2013, Volume 91, Number 5, Page 623
[5]
Hui-Chun Tsuang, Wei J. Chen, Sheng-Hsiang Lin, Teng-Yi Chen, Yi-Lin Chang, Kuo-Hao Huang, and Hsien-Yuan Lane
Psychiatry Research, 2013, Volume 208, Number 2, Page 105
[6]
R. Słopień, A. Słopień, A. Różycka, A. Warenik-Szymankiewicz, M. Lianeri, and P. P. Jagodziński
The Scientific World Journal, 2012, Volume 2012, Page 1
[8]
Charles D. Nichols
Cardiovascular Psychiatry and Neurology, 2009, Volume 2009, Page 1
[9]
Pedro Dorado, Eva M Pe as-LLed, and Adri n LLerena
Pharmacogenomics, 2007, Volume 8, Number 11, Page 1597
[10]
M. V. Alfimova, M. V. Monakhov, L. I. Abramova, S. A. Golubev, and V. E. Golimbet
Neuroscience and Behavioral Physiology, 2010, Volume 40, Number 8, Page 934

Comments (0)

Please log in or register to comment.